These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 28424324)
1. Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study. Cella CA; Di Minno G; Carlomagno C; Arcopinto M; Cerbone AM; Matano E; Tufano A; Lordick F; De Simone B; Muehlberg KS; Bruzzese D; Attademo L; Arturo C; Sodano M; Moretto R; La Fata E; De Placido S Oncologist; 2017 May; 22(5):601-608. PubMed ID: 28424324 [TBL] [Abstract][Full Text] [Related]
2. Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer. Cella CA; Knoedler M; Hall M; Arcopinto M; Bagnardi V; Gervaso L; Pellicori S; Spada F; Zampino MG; Ravenda PS; Frassoni S; Passaro A; Milano M; Laffi A; Fazio N; Lordick F JAMA Netw Open; 2023 Feb; 6(2):e230010. PubMed ID: 36795409 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancer. Cella CA; Djulbegovic B; Hozo I; Lordick F; Bagnardi V; Frassoni S; Gervaso L; Fazio N Eur J Cancer; 2024 Sep; 209():114234. PubMed ID: 39142210 [TBL] [Abstract][Full Text] [Related]
4. ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis. Godinho J; Casa-Nova M; Moreira-Pinto J; Simões P; Paralta Branco F; Leal-Costa L; Faria A; Lopes F; Teixeira JA; Passos-Coelho JL Oncologist; 2020 Feb; 25(2):e284-e290. PubMed ID: 32043787 [TBL] [Abstract][Full Text] [Related]
5. Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer. Parker A; Peterson E; Lee AYY; de Wit C; Carrier M; Polley G; Tien J; Wu C J Thromb Haemost; 2018 Jul; 16(7):1321-1326. PubMed ID: 29733498 [TBL] [Abstract][Full Text] [Related]
6. Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre. Pelletier R J Oncol Pharm Pract; 2021 Jun; 27(4):911-918. PubMed ID: 33757321 [TBL] [Abstract][Full Text] [Related]
7. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model. Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293 [TBL] [Abstract][Full Text] [Related]
8. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study. Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831 [TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism in cancer patients. Deng A; Galanis T; Graham MG Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915 [TBL] [Abstract][Full Text] [Related]
10. A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts. Muñoz A; Ay C; Grilz E; López S; Font C; Pachón V; Castellón V; Martínez-Marín V; Salgado M; Martínez E; Calzas J; Ortega L; Rupérez A; Salas E; Pabinger I; Soria JM J Clin Oncol; 2023 Jun; 41(16):2911-2925. PubMed ID: 36730884 [TBL] [Abstract][Full Text] [Related]
11. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study. Gerotziafas GT; Taher A; Abdel-Razeq H; AboElnazar E; Spyropoulos AC; El Shemmari S; Larsen AK; Elalamy I; Oncologist; 2017 Oct; 22(10):1222-1231. PubMed ID: 28550032 [TBL] [Abstract][Full Text] [Related]
12. Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients. Di Nisio M; van Es N; Rotunno L; Anzoletti N; Falcone L; De Tursi M; Natoli C; Tinari N; Cavallo I; Valeriani E; Candeloro M; Guglielmi MD; Rutjes AWS; Porreca E J Thromb Thrombolysis; 2019 Jul; 48(1):125-133. PubMed ID: 30919253 [TBL] [Abstract][Full Text] [Related]
13. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies. Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832 [TBL] [Abstract][Full Text] [Related]
14. Four years of an aggressive prophylaxis and screening protocol for venous thromboembolism in a large trauma population. Adams RC; Hamrick M; Berenguer C; Senkowski C; Ochsner MG J Trauma; 2008 Aug; 65(2):300-6; discussion 306-8. PubMed ID: 18695464 [TBL] [Abstract][Full Text] [Related]
15. Primary prophylaxis of VTE in cancer outpatients. Imberti D; Benedetti R Thromb Res; 2016 Apr; 140 Suppl 1():S103-8. PubMed ID: 27067962 [TBL] [Abstract][Full Text] [Related]
17. Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool. Patell R; Rybicki L; McCrae KR; Khorana AA Am J Hematol; 2017 Jun; 92(6):501-507. PubMed ID: 28240823 [TBL] [Abstract][Full Text] [Related]
18. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study. Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201 [TBL] [Abstract][Full Text] [Related]
19. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Di Nisio M; Ferrante N; De Tursi M; Iacobelli S; Cuccurullo F; Büller HR; Feragalli B; Porreca E Thromb Haemost; 2010 Nov; 104(5):1049-54. PubMed ID: 20806119 [TBL] [Abstract][Full Text] [Related]
20. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Khorana AA; Dalal M; Lin J; Connolly GC Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]